BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 24014567)

  • 1. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
    Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
    Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide profiling of target genes for the systemic lupus erythematosus-associated transcription factors IRF5 and STAT4.
    Wang C; Sandling JK; Hagberg N; Berggren O; Sigurdsson S; Karlberg O; Rönnblom L; Eloranta ML; Syvänen AC
    Ann Rheum Dis; 2013 Jan; 72(1):96-103. PubMed ID: 22730365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population.
    Kobayashi S; Ikari K; Kaneko H; Kochi Y; Yamamoto K; Shimane K; Nakamura Y; Toyama Y; Mochizuki T; Tsukahara S; Kawaguchi Y; Terai C; Hara M; Tomatsu T; Yamanaka H; Horiuchi T; Tao K; Yasutomo K; Hamada D; Yasui N; Inoue H; Itakura M; Okamoto H; Kamatani N; Momohara S
    Arthritis Rheum; 2008 Jul; 58(7):1940-6. PubMed ID: 18576330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors.
    Suarez-Gestal M; Calaza M; Dieguez-Gonzalez R; Perez-Pampin E; Pablos JL; Navarro F; Narvaez J; Marenco JL; Herrero-Beaumont G; Fernandez-Gutierrez B; Lamas JR; de la Serna AR; Ortiz AM; Carreño L; Cañete JD; Caliz R; Blanco FJ; Balsa A; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2009 Sep; 60(9):2558-64. PubMed ID: 19714582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-gene interactions of IRF5, STAT4, IKZF1 and ETS1 in systemic lupus erythematosus.
    Dang J; Shan S; Li J; Zhao H; Xin Q; Liu Y; Bian X; Liu Q
    Tissue Antigens; 2014 Jun; 83(6):401-8. PubMed ID: 24697319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts.
    Nordang GB; Viken MK; Amundsen SS; Sanchez ES; Flatø B; Førre OT; Martin J; Kvien TK; Lie BA
    Rheumatology (Oxford); 2012 Apr; 51(4):619-26. PubMed ID: 22179739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.
    Shimane K; Kochi Y; Yamada R; Okada Y; Suzuki A; Miyatake A; Kubo M; Nakamura Y; Yamamoto K
    Ann Rheum Dis; 2009 Mar; 68(3):377-83. PubMed ID: 18408250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis.
    Dieguez-Gonzalez R; Calaza M; Perez-Pampin E; de la Serna AR; Fernandez-Gutierrez B; Castañeda S; Largo R; Joven B; Narvaez J; Navarro F; Marenco JL; Vicario JL; Blanco FJ; Fernandez-Lopez JC; Caliz R; Collado-Escobar MD; Carreño L; Lopez-Longo J; Cañete JD; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2008 May; 58(5):1264-74. PubMed ID: 18438842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.
    Hellquist A; Järvinen TM; Koskenmies S; Zucchelli M; Orsmark-Pietras C; Berglind L; Panelius J; Hasan T; Julkunen H; D'Amato M; Saarialho-Kere U; Kere J
    J Rheumatol; 2009 Aug; 36(8):1631-8. PubMed ID: 19567624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposed independent effects and epistasis in the complex association of IRF5 to SLE.
    Ferreiro-Neira I; Calaza M; Alonso-Perez E; Marchini M; Scorza R; Sebastiani GD; Blanco FJ; Rego I; Pullmann R; Pullmann R; Kallenberg CG; Bijl M; Skopouli FN; Mavromati M; Migliaresi S; Barizzone N; Ruzickova S; Dostal C; Schmidt RE; Witte T; Papasteriades C; Kappou-Rigatou I; Endreffy E; Kovacs A; Ordi-Ros J; Balada E; Carreira P; Gomez-Reino JJ; Gonzalez A
    Genes Immun; 2007 Jul; 8(5):429-38. PubMed ID: 17568788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians.
    Palomino-Morales RJ; Rojas-Villarraga A; González CI; Ramírez G; Anaya JM; Martín J
    Genes Immun; 2008 Jun; 9(4):379-82. PubMed ID: 18432273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT4 confers risk for rheumatoid arthritis and systemic lupus erythematosus in Mexican patients.
    Beltrán Ramírez O; Mendoza Rincón JF; Barbosa Cobos RE; Alemán Ávila I; Ramírez Bello J
    Immunol Lett; 2016 Jul; 175():40-3. PubMed ID: 27178308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis.
    Rueda B; Reddy MV; González-Gay MA; Balsa A; Pascual-Salcedo D; Petersson IF; Eimon A; Paira S; Scherbarth HR; Pons-Estel BA; González-Escribano MF; Alarcón-Riquelme ME; Martín J
    Arthritis Rheum; 2006 Dec; 54(12):3815-9. PubMed ID: 17133578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis.
    Tang L; Chen B; Ma B; Nie S
    Genet Mol Res; 2014 Jun; 13(2):4473-85. PubMed ID: 25036352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis.
    Garnier S; Dieudé P; Michou L; Barbet S; Tan A; Lasbleiz S; Bardin T; Prum B; Cornélis F
    Ann Rheum Dis; 2007 Jun; 66(6):828-31. PubMed ID: 17158136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome.
    Yin H; Borghi MO; Delgado-Vega AM; Tincani A; Meroni PL; Alarcón-Riquelme ME
    Arthritis Rheum; 2009 Aug; 60(8):2468-71. PubMed ID: 19644876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population.
    Järvinen TM; Hellquist A; Zucchelli M; Koskenmies S; Panelius J; Hasan T; Julkunen H; D'Amato M; Kere J
    Rheumatology (Oxford); 2012 Jan; 51(1):87-92. PubMed ID: 22039224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
    Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
    Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.